Exploring the Use of ECochG Testing During Electrode Insertion in Cochlear Implant Surgery
Launched by CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST · Jan 16, 2019
Trial Information
Current as of June 13, 2025
Completed
Keywords
ClinConnect Summary
Cochlear implant candidature has changed in the past years. Today many cochlear implant recipients have some low frequency residual hearing in the ear which is to be implanted. To help preserve hearing, the electrode array must be inserted extremely carefully. It is desirable to have real-time feedback relating to progress of the electrode insertion.
One possible tool that might provide this is an electrocochleography (ECochG). A brief low-frequency acoustic tone at a fixed level is delivered to the external ear canal. This results in normal movements of the outer and the inner hair cells ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients between ages of 12 months to 6 years old, and Adults over 18 years old
- • Meets normal candidacy requirements for cochlear implantation
- • Advanced Bionics (AB) implant has been selected for patient at MDT
- • Patient has capacity to consent
- • Patent cochlea as verified by CT or MRI scan
- • No cochlear abnormality that might prevent insertion of the electrode array
- • Measurable residual hearing in the ear to be implanted
- • No additional handicap that would prevent study procedures being followed
- • Agreement to participate in the study
- Exclusion Criteria:
- • Complex cases where minimal duration of surgery is required. Although ECochG adds less than 10 minutes to the surgery time.
- • Patients lacking the capacity to consent
About Cambridge University Hospitals Nhs Foundation Trust
Cambridge University Hospitals NHS Foundation Trust is a leading healthcare organization in the UK, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent academic health science center, it integrates cutting-edge research with clinical practice, fostering collaboration between healthcare professionals, researchers, and patients. The Trust is committed to delivering high-quality, evidence-based healthcare while actively participating in the development of new therapies and interventions aimed at enhancing health outcomes. With a focus on excellence in clinical research, Cambridge University Hospitals aims to translate scientific discoveries into effective treatments, ultimately benefiting the wider community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cambridge, , United Kingdom
Patients applied
Trial Officials
Manohar L Bance, MD
Principal Investigator
The Emmeline Centre for Cochlear Implants
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials